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ABSTRACT
Background and objective The differential diagnosis 
for exercise- associated breathlessness is broad, 
however, when a young athletic individual presents with 
respiratory symptoms, they are most often prescribed 
inhaler therapy for presumed exercise- induced asthma 
(EIA). The purpose of this study was therefore to use a 
novel sound- based approach to assessment to evaluate 
the prevalence of exertional respiratory symptoms and 
characterise abnormal breathing sounds in a large cohort 
of recreationally active individuals.
Methods Cross- sectional field- based evaluation of 
individuals completing Parkrun.
Phase 1 Prerace, clinical assessment and baseline 
spirometry were conducted. At peak exercise and 
immediately postrace, breathing was monitored 
continuously using a smartphone. Recordings were 
analysed retrospectively and coded for signs of the 
predominant respiratory noise.
Phase 2 A subpopulation that reported symptoms with 
at least one audible sign of respiratory dysfunction was 
randomly selected and invited to attend the laboratory on a 
separate occasion to undergo objective clinical workup to 
confirm or refute EIA.
Results Forty- eight participants (22.6%) had at least 
one audible sign of respiratory dysfunction; inspiratory 
stridor (9.9%), expiratory wheeze (3.3%), combined 
stridor+wheeze (3.3%), cough (6.1%). Over one- third of 
the cohort (38.2%) were classified as symptomatic. Ten 
individuals attended a follow- up appointment, however, 
only one had objective evidence of EIA.
Conclusions The most common audible sign, detected in 
approximately 1 in 10 individuals, was inspiratory stridor, 
a characteristic feature of upper airway closure occurring 
during exercise. Further work is now required to further 
validate the precision and feasibility of this diagnostic 
approach in cohorts reporting exertional breathing 
difficulty.
INTRODUCTION
The differential diagnosis for exercise- 
associated breathlessness with wheeze is 
broad,1 however, when a young athletic 
individual reports this problem, they are 
most often prescribed inhaler therapy for 
a presumed diagnosis of exercise- induced 
asthma (EIA).2 This is despite a substantial 
body of evidence indicating a poor associ-
ation between the presence of exertional 
respiratory symptoms and objective evidence 
of EIA.3 4
The limited predictive value of symptoms, 
in this context, is likely explained by the 
presence of conditions that can act to mimic 
EIA. In this respect, closure of the laryn-
geal inlet (upper airway) during exercise—a 
condition termed exercise- induced laryngeal 
obstruction (EILO) is recognised to precipi-
tate breathlessness and wheeze.5 6 EILO is a 
common condition, affecting between 5% 
and 7% in adolescents,7 with a higher prev-
alence in athletes and military personnel 
(15%–35%),8 9 but can also exist as a comorbid 
phenomenon in approximately one in four 
patients with asthma.10 11
A key difference between EILO and EIA 
is the nature and quality of the respiratory 
sound that develops during exercise. Specif-
ically, EILO is typically associated with an 
inspiratory phase stridor, that is present 
during exercise, whereas in contrast, EIA can 
Key messages
What is the key question?
 ► To use a novel sound- based approach to assess-
ment to evaluate and characterise abnormal breath-
ing sounds in a large cohort of recreationally active 
individuals.
What is the bottom line?
 ► The most common audible sign, detected in approx-
imately 1 in 10 individuals, was inspiratory stridor, a 
characteristic feature of upper airway closure occur-
ring during exercise.
Why read on?
 ► This study demonstrates the potential value of field- 
based smartphone audio recordings as a simple 
screening modality or adjunctive tool to aid the as-
sessing clinician in an office- based setting to guide 
clinical workup and inform subsequent diagnostic 
referral.
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be associated with expiratory wheeze, often maximal in 
the postexercise period. Thus, a unique but mandatory 
requirement, in the assessment of patients who report 
exertional breathlessness, is the ability to evaluate respi-
ratory sounds during exercise (ie, not simply in the clinic 
room).
The gold- standard method to confirm a diagnosis of 
EILO is the continuous laryngoscopy during exercise test 
(CLE)12, a technique that involves flexible nasendoscopy, 
to allow visualisation of the laryngeal structures during 
laboratory- based exercise. Although the feasibility of 
this approach is well established, CLE is currently only 
available at specialist centres across Europe and requires 
expensive comprehensive setup and expertise, and thus 
deemed impractical for field- based assessment. Alterna-
tive detection methods used in this setting have included 
evaluating the origin of respiratory sounds by auscul-
tating the neck and chest, during exercise. Previously, a 
high prevalence of inspiratory stridor has been reported 
when employing sound- based stethoscope assessment 
during exercise challenge testing in athletes screened for 
EIA.13
The purpose of this study was therefore to use a novel 
sound- based approach to assess and evaluate the prev-
alence of exertional respiratory symptoms and char-
acterise abnormal breathing sounds in a large cohort 
of recreationally active individuals. Due to the typical 
features associated with upper and lower airway obstruc-
tion during exercise (ie, high- pitched stridor or ‘whistle’ 
on inspiration and expiratory wheeze, respectively), we 
hypothesised that self- recorded audio using smartphones 
could offer utility as a screening modality to guide clin-
ical workup and inform subsequent diagnostic referral.
METHODS
Study population
Two hundred and twenty recreational runners (men: 
n=100) currently meeting the American College of 
Sports Medicine physical activity recommendations were 
enrolled into the study.14 All were non- smokers and free 
from respiratory, cardiovascular, metabolic and psychi-
atric disease and any other significant medical condition 
except asthma.
Patient and public involvement
Patients were not involved in the design of this study.
Experimental design
The study was conducted as a cross- sectional field- based 
evaluation of individuals completing Parkrun across 
Northern England between 2017 and 2019. Phase 1. 
Prerace, preparticipation health screening, clinical assess-
ment and baseline spirometry were conducted prior to 
completing a 5 km time- trial run. At peak exercise and 
immediately postrace, breathing was self- recorded by 
the participant and analysed, retrospectively (figure 1). 
Phase 2. A subpopulation that reported symptoms and 
at least one audible sign of respiratory dysfunction was 
randomly selected and invited to attend the laboratory 
on a separate occasion to undergo objective clinical 
workup to confirm or refute EIA.
PHASE 1
Clinical assessment and baseline lung function
Respiratory symptoms were assessed via completion of 
the Allergy Questionnaire for Athletes (AQUA) (AQUA 
score: 0–30) and Dyspnoea-12 (D-12 score:1–36). The 
AQUA has previously been validated to evaluate allergic 
and respiratory symptoms in athletes15 16—whereas 
D-12 quantifies the physical and affective components 
of breathlessness.17 A combined positive AQUA score 
≥5 and D-12 score ≥1 was used to confirm symptomatic 
status. Lung function was assessed by maximal forced 
flow- volume spirometry with established reference values 
employed in accordance with international guidelines.18
Audio-recordings and sound analysis
Breathing sounds during exercise were self- recorded by 
the participant using an in- built audio- recording appli-
cation on a smartphone. At the start of the race, partic-
ipants launched the application in preparation to begin 
recording at peak exercise (ie, approaching and crossing 
the finish line) and immediately postrace for 15 min or 
until resting tidal breathing had resumed. To optimise 
signal- to- noise ratio (ie, minimise distortion and back-
ground noise), participants were instructed to hold the 
smartphone approximately 10–15 cm away from their 
Figure 1 Schematic detailing experimental design.
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mouth. Audio- recordings were analysed retrospectively 
by two independent researchers (JS and OJP) and coded 
for signs of the predominant respiratory noise: 0=nil; 
1=inspiratory stridor (defined as a monophonic high- 
pitched ‘whistle’ on inspiration); 2=expiratory wheeze 
(defined as a polyphonic ‘whistle or rattle’ on expira-
tion); 3=combined stridor+wheeze; 4=cough.
PHASE 2
Fractional exhaled nitric oxide and eucapnic voluntary 
hyperpnoea
Airway inflammation was assessed via fractional exhaled 
nitric oxide (FeNO) using a handheld measuring device 
(NIOX VERO; Aerocrine AB, Stockholm, Sweden).19 
Eucapnic voluntary hyperpnoea (EVH) was conducted as 
previously described.20 In brief, participants breathed a 
dry compressed gas mixture (21% O2, 5% CO2, balance 
N2) at a target ventilation rate equivalent to 85% (base-
line FEV1×30) of their predicted maximal voluntary venti-
lation (MVV) for 6 min. Spirometry was performed in 
triplicate at baseline and in duplicate at 3, 5, 7, 10 and 
15 mins post- EVH. Values within 5% were considered 
acceptable. The highest recorded value at each time 
point was used for analysis. A positive diagnosis for EIA 
was defined by a fall in forced expiratory volume in one 
second (FEV1)≥15% at one time point.
21
Statistical analysis
Data were stratified with cross tabulation and reported 
descriptively according to the prevalence of respira-
tory symptoms and audible code (ie, sign of respiratory 
dysfunction). Independent t- tests (continuous varia-
bles) and χ2 tests (categorical variables) were employed 
to evaluate between- group differences. The relation-
ship between variables was evaluated using Spearman’s 
correlation coefficient. Data are reported as mean±SD 
(normal distribution) or median and IQR (non- normal 
distribution). Data were analysed using SPSS Statistics 
V.24 statistical software package (SPSS, V.21, Chicago, Illi-
nois, USA). p<0.05 was considered statistically significant.
RESULTS
Clinical characteristics and baseline lung function
Two- hundred and twenty recreational runners consented 
to participate in the study. Eight individuals failed to 
provide a postrace audio recording and thus 212 partic-
ipants (men: n=95) were included in the analysis. The 
majority of the cohort (86%) had normal resting lung 
function (FEV1>80% predicted and FEV1/FVC ratio 
>70%). Forty- one (19.3%) (men: n=19) reported a prior 
physician- based asthma diagnosis. Three individuals 
(7.3%) with asthma had evidence of expiratory airflow 
limitation (FEV1/FVC ratio <70%). Participants with 
asthma had a lower FEV1/FVC ratio (p=0.003), however, 
no difference was observed in any other pulmonary func-
tion parameters (p>0.05) (table 1).
PHASE 1
Exertional respiratory symptoms
One hundred and eighteen participants (55.6%) 
provided a positive AQUA questionnaire (AQUA score 
range: 0–30) and 121 (57.1%) reported heightened 
perceived breathlessness (D-12 score range: 0–26). 
Eighty- one (38.2%) were thus classified as being symp-
tomatic (ie, positive to both AQUA and D-12) (figure 2). 
Of these, 54 were women (66.7%) and 27 were men 
(33.3%) (p=0.008). A higher proportion of individuals 
with asthma reported exertional breathing difficulty in 
comparison to their healthy counterparts (p<0.001).
Audible signs of respiratory dysfunction
Forty- eight participants (22.6%) had at least one audible 
sign of respiratory dysfunction; inspiratory stridor (9.9%), 
expiratory wheeze (3.3%), combined stridor+wheeze 
(3.3%), cough (6.1%) (ie, inspiratory stridor was the 
most common audible sign) (see online supplemental 
audio file 1), with no difference apparent between men 
and women (p=0.62). Fifteen individuals with a prior 
asthma diagnosis (36.6%) also had an audible sign; 
inspiratory stridor (14.6%), expiratory wheeze (7.3%), 
combined stridor+wheeze (7.3%), cough (7.3%). The 
proportion of individuals with an audible sign was higher 
in those with asthma in comparison to healthy individ-
uals (p=0.02).
Exertional respiratory symptoms+audible sign
Twenty- eight participants (13.2%) had evidence of both 
symptoms and an audible sign: inspiratory stridor (4.2%); 
expiratory wheeze (1.9%); combined stridor+wheeze 
(2.8%); cough (4.2%). Of these, 22 were women (78.6%) 
and 6 (21.4%) were men (p=0.008). The proportion of 
individuals with both symptoms and an audible sign was 
higher in those with an asthma diagnosis when compared 
Table 1 Clinical characteristics and baseline lung function
Variables Mean (±SD) Median (IQR)
Age (year) 36 ± 13 35 (25)
Height (cm) 172.1 ± 9.2 172.0 (13.3)
Weight (kg) 71.6 ± 12.8 69.0 (16.3)
BMI (kg•m-2) 24 ± 3 24 (4)
FEV1 (L) 3.72 ± 0.85 3.7 (1.2)
FEV1 %predicted 97.8 ± 15.5 97.2 (23.5)
FVC (L) 4.06 ± 1.07 4.5 (1.5)
FVC %predicted 117.8 ± 17.2 118.2 (24.3)
FEV1/FVC (%) 82.6 ± 7.6 83.0 (9)
D-12 score 3 ± 5 2 (5)
AQUA score 8 ± 8 6 (13)
AQUA, Allergy Questionnaire for Athletes; BMI, body mass index; 
D-12, Dyspnoea-12; Forced expiratory volume in one second, 
FEV1; Forced vital capacity, FVC.
copyright.
 o
n
 O
ctober 8, 2020 by guest. Protected by
http://bmjopenrespres.bmj.com/
BM
J O
pen Resp Res: first published as 10.1136/bmjresp-2020-000618 on 30 September 2020. Downloaded from 
4 Sails J, et al. BMJ Open Resp Res 2020;7:e000618. doi:10.1136/bmjresp-2020-000618
Open access
with healthy individuals (p=0.002). A weak association 
was observed between audible signs and symptomatic 
status (r=0.2, p=0.001). Importantly, 20 asymptomatic 
individuals (9.4%) had an audible sign: inspiratory 
stridor (5.7%); expiratory wheeze (1.4%); combined stri-
dor+wheeze (0.5%); cough (1.9%)—whereas 33 (15.6%) 
symptomatic individuals did not present with an audible 
sign.
PHASE 2
EIA screening outcome
Ten symptomatic individuals with audible respiratory 
dysfunction (3 inspiratory stridor, 3 combined stri-
dor+wheeze and 4 cough) agreed to attend a follow- up 
appointment to complete FeNO and EVH. Of these, 
three had elevated airway inflammation (ie, FeNO 
≥25 ppb) but normal baseline lung function. All met the 
accepted minimal target ventilation for a valid test EVH 
(ie, minute ventilation ≥60% MVV). Only one individual 
(combined stridor+wheeze) had objective evidence of 
EIA (−25% reduction in FEV1) (table 2).
DISCUSSION
In a large cohort of recreational runners, we found that a 
substantial proportion of individuals has an audible sign 
of respiratory dysfunction, during their routine weekly 
exercise. Importantly, the most frequently detected noise, 
affecting approximately 1 in 10 individuals, was inspir-
atory stridor. This challenges the widespread miscon-
ception that any exercise- associated ‘wheeze’ must be 
arising from EIA and is supported by the finding that 
the majority of those with a prior physician- based asthma 
diagnosis actually had evidence of inspiratory stridor.
Respiratory noise on exertion is thought to be gener-
ated by vibrations within the airway structures in the 
presence of turbulent airflow or vortices.22 In healthy 
individuals undertaking exercise, both the upper and 
lower airways dilate mildly to facilitate ventilation and 
decrease airway resistance.23–25 The presence of stridor, 
a monophonic high- pitched sound heard on inspiration, 
during exercise, indicates narrowing in the extrathoracic 
airway and most often transient closure of the larynx.26 In 
contrast, expiratory wheeze is commonly associated with 
lower airway narrowing and often detected in conditions 
characterised by expiratory airflow limitation (ie, intra-
thoracic airway obstruction).26 Despite this, the presence 
of any ‘abnormal’ loud or noisy breathing on exertion 
is most often associated and interpreted as a character-
istic feature of EIA.27 The low prevalence of objectively 
confirmed airway hyper- responsiveness with bronchial 
provocation testing, in the subgroup of patients with 
audible respiratory dysfunction, underlines the poor 
predictive value of a symptom- based approach to clinical 
assessment.3 4 Likewise, it has been recognised for some 
time that resting spirometry provides limited predictive 
value in this setting28 and thus highlights the importance 
Table 2 Screening outcome following EVH
Gender Age (year) BMI (kg•m-2) Audible sign FeNO (ppb) EVH (% fall in FEV1) EIA
M 55 24 Inspiratory stridor 37* −1.6 Negative
F 50 24 Inspiratory stridor 18 −5.3 Negative
F 38 25 Inspiratory stridor 18 −3.7 Negative
F 24 22 Stridor+wheeze 31* −25.1† Positive
M 26 27 Stridor+wheeze 19 −4.2 Negative
F 21 23 Stridor+wheeze 17 −1.4 Negative
F 59 24 Cough 15 −5.5 Negative
F 46 29 Cough 16 −6.0 Negative
M 25 28 Cough 19 −8.3 Negative
F 36 24 Cough 40* −0.5 Negative
*FeNO ≥25 ppb (intermediate).
†EIA ≥15% fall in FEV1.
BMI, body mass index; EIA, exercise- induced asthma; EVH, eucapnic voluntary hyperpnoea; FeNO, fractional exhaled nitric oxide.
Figure 2 Prevalence of exertional respiratory symptoms 
and audible signs of respiratory dysfunction.
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and indeed requirement to detect and evaluate exer-
tional respiratory disorders during physical activity. 
Overall, therefore, our findings challenge the validity of 
a ‘clinic- based approach’ and typical view or practice that 
breathlessness and wheeze on exertion equate to asthma. 
Our findings also act to demonstrate the potential value 
of employing modern technologies to conduct field- 
based testing to truly understand the cause of an individ-
ual’s respiratory symptoms. From a practical perspective, 
audio recordings may therefore offer value as an adjunc-
tive tool to aid the assessing clinician in an office- based 
setting to ensure that patients are referred for the most 
appropriate tests to achieve early accurate diagnosis. It is 
important to recognise, however, that despite their appar-
ently ‘asymptomatic’ status, 20 individuals had an audible 
sign of respiratory dysfunction. We used screening ques-
tionnaires to detect symptoms and it may be that direct 
questioning±consultation may have provided further 
clinical insight. It is also plausible that individuals who 
have experienced exertional breathing difficulty for a 
sustained period become accustomed and associate the 
sensation of dyspnoea as a ‘normal’ or a typical response 
to vigorous exercise.4 Indeed, screening studies in 
athletic cohorts consistently reveal individuals who fail to 
perceive respiratory symptoms yet report improvements 
in exercise ventilatory function following intervention.29 
In this respect, audio recordings may also have utility as 
a low- cost pragmatic first step to widespread screening 
programmes in sports teams, schools or athletic squads.
The prevalence of respiratory symptoms in the current 
study was comparable with the previous population- 
based research in athletic cohorts.30 31 Indeed, over half 
of the study population scored positively on the AQUA 
questionnaire15—with a similar number reporting a 
heightened D-12 score. Although the development of 
breathlessness and a degree of respiratory discomfort 
is considered a physiologically appropriate response to 
exercise, potentially reflecting heightened ventilatory 
drive due to increased work of breathing32; in some 
individuals, these sensations are considered excessive or 
inappropriate and may relate to an underlying abnor-
mality or pathological condition.33 We used a combined 
positive AQUA and D-12 score that resulted in over one- 
third of the cohort being classified as symptomatic, and 
similar to previous studies, respiratory symptoms were 
most frequently reported in women.31 34 35 Although 
the underlying physiological mechanism(s) to explain 
the disparity in symptom perception between genders 
remains unclear, previous reports suggest that the preva-
lence of EILO is most common in adolescents and young 
women.36 37 In keeping with this concept, a significantly 
higher proportion of symptomatic women also had an 
audible sign of respiratory distress. Other factors that 
may explain or contribute to gender differences include 
the fact that women have lower absolute lung volumes 
impacting expiratory flow limitation, smaller airway 
diameters, differences in respiratory muscle function 
and a lower surface area for pulmonary gas exchange 
in comparison with men.38 39 The higher prevalence of 
symptoms in those with asthma is expected given exercise 
is one of the most frequently reported symptom triggers 
and a prominent clinical characteristic of the disease.40
Methodological considerations and future research
A key limitation of the present study is the lack of validity 
work demonstrating that inspiratory stridor was caused 
by EILO. Thus, a logical extension of this study and focus 
for future research should be to determine the value of 
our approach to sound recordings in asymptomatic and 
symptomatic individuals against objective test results 
(ie, bronchial provocation or CLE testing) to determine 
diagnostic sensitivity and specificity. It is important to 
highlight that we were unable to detect a sign of respira-
tory dysfunction in 33 symptomatic individuals and 
thus a sound- based approach to detection should not 
be used to preclude underlying airflow limitation. It is 
also worth noting that differences in smartphone brand 
or model may impact audio quality (ie, ability to detect 
‘abnormal’ breathing sounds) and despite attempting to 
standardise the position of the smartphone, a degree of 
between- subject variability is inevitable when employing 
this approach. Irrespective, our findings indicate that it 
is possible to discern between audible signs of respiratory 
dysfunction in most cases by using modern smartphone 
audio recording technology. Indeed, the accessible and 
user- friendly nature of these devices and current wide-
spread use of social fitness network applications (eg, 
Strava and MapMyRun, etc) within the general popula-
tion highlights the potential to implement and use this 
approach as a simple screening modality. The develop-
ment of a targeted ‘fit for purpose’ ambulatory device 
with increased signal- to- noise ratio to detect, analyse 
and interpret signs of respiratory dysfunction therefore 
remains an important avenue for future research.
CONCLUSION
In summary, a high proportion of individuals engaging 
in recreational sport develop respiratory symptoms and 
audible respiratory dysfunction during exercise. The 
most common audible sign, detected in approximately 1 
in 10 individuals, was inspiratory stridor, a characteristic 
feature of upper airway closure occurring during exer-
cise. Further work is now required to further validate the 
precision and feasibility of this diagnostic approach in 
cohorts reporting exertional breathing difficulty.
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